China has banned the surgical treatment of Alzheimer’s disease after concerns about its safety and effectiveness.
The procedure known as lymphatic-venous anastomosis (LVA) aimed to boost the removal of harmful brain proteins to slow the disease's progression.
The National Health Commission found a lack of high-quality evidence supporting the safety and efficacy of this surgery for Alzheimer's treatment.
Local health authorities have been advised to halt Alzheimer's treatment with LVA surgery until more evidence is gathered, despite the procedure's growing popularity in China.